ClinVar Miner

Submissions for variant NM_181426.2(CCDC39):c.1874G>T (p.Ser625Ile)

gnomAD frequency: 0.00006  dbSNP: rs769223754
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000214679 SCV000271541 uncertain significance not specified 2016-01-29 criteria provided, single submitter clinical testing The p.Ser625Ile variant in CCDC39 has not been previously reported in individual s with pulmonary disease, but has been identified in 10/65788 European chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs769223754). Computational prediction tools and conservation analysis sugge st that the p.Ser625Ile variant may impact the protein, though this information is not predictive enough to determine pathogenicity. This variant is located in the last three bases of the exon, which is part of the 5? splice region. Computa tional tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pathogenicity. In summary, the clinical signif icance of the p.Ser625Ile variant is uncertain.
Invitae RCV000233515 SCV000291752 pathogenic Primary ciliary dyskinesia 2023-10-26 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 625 of the CCDC39 protein (p.Ser625Ile). This variant also falls at the last nucleotide of exon 13, which is part of the consensus splice site for this exon. This variant is present in population databases (rs769223754, gnomAD 0.01%). This missense change has been observed in individual(s) with primary ciliary dyskinesia (Invitae). ClinVar contains an entry for this variant (Variation ID: 228475). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV000233515 SCV002717828 likely pathogenic Primary ciliary dyskinesia 2019-07-30 criteria provided, single submitter clinical testing The p.S625I variant (also known as c.1874G>T), located in coding exon 13 of the CCDC39 gene, results from a G to T substitution at nucleotide position 1874. The amino acid change results in serine to isoleucine at codon 625, an amino acid with dissimilar properties. However, this change occurs in the last base pair of coding exon 13, which makes it likely to have some effect on normal mRNA splicing. This alteration has been detected in trans with a pathogenic mutation in CCDC39 by our laboratory. Both the nucleotide and amino acid positions are highly conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to abolish the native splice donor site; however, direct evidence is unavailable. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Preventiongenetics, part of Exact Sciences RCV003417772 SCV004113913 likely pathogenic CCDC39-related condition 2023-05-10 criteria provided, single submitter clinical testing The CCDC39 c.1874G>T variant is predicted to result in the amino acid substitution p.Ser625Ile. To our knowledge, this variant has not been reported in the literature. This variant occurs at the last nucleotide of exon 13 in CCDC39 and is predicted to weaken the canonical splice donor site based on available splicing prediction programs (Alamut Visual v1.6.1). This variant has been confirmed in trans with a pathogenic CCDC39 variant in one individual with clinical features of primary ciliary dyskinesia (Internal Data, PreventionGenetics). This variant is reported in 0.013% of alleles in individuals of European (non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-180359781-C-A). This variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.